Today, Clonit srl acquires Euroclone Diagnostica s.r.l. which operates both at local and international level in the human diagnostic market segment and in particular in the area of Molecular Biology.
As Clonit, Euroclone Diagnostica SRL’s core business is the development, production and sale of innovative products. The Company has a number of strategic collaborations with various Research Organisations in Europe, a team of highly motivated managers, product and technical specialists and also either local direct sales network or international distributors network to consolidate EuroClone Diagnostica SRL business.
The complementarity between the two companies make the acquisition a starting point for a new CLONIT with more knowledge and more business relationship. The new products portfolio will be a merging of the excellences and will allows to propose increasingly competitive solutions to respond to the new challenges of the market (Dario Russo - Clonit CEO).